The Trump administration has revoked $766 million in funding awarded to Moderna Inc. for a potential bird flu vaccine. The company's mRNA-1018 vaccine showed promising results in a trial. The cancellation adds uncertainty, despite the vaccine's safety and efficacy against Covid-19.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing